-
1
-
-
0035138842
-
Extracellular calcium sensing and extracellular calcium signaling
-
Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev. 2001;81(1):239-297 (Pubitemid 32096177)
-
(2001)
Physiological Reviews
, vol.81
, Issue.1
, pp. 239-297
-
-
Brown, E.M.1
Macleod, R.J.2
-
2
-
-
40149084169
-
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations
-
DOI 10.1016/j.berh.2007.11.006, PII S1521694207001301
-
Egbuna OI, Brown EM. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol. 2008;22(1):129-148 (Pubitemid 351325733)
-
(2008)
Best Practice and Research: Clinical Rheumatology
, vol.22
, Issue.1
, pp. 129-148
-
-
Egbuna, O.I.1
Brown, E.M.2
-
3
-
-
0038102866
-
Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues
-
DOI 10.1097/00041552-200307000-00002
-
Quarles LD. Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues. Curr Opin Nephrol Hypertens. 2003;12(4):349-355 (Pubitemid 36871857)
-
(2003)
Current Opinion in Nephrology and Hypertension
, vol.12
, Issue.4
, pp. 349-355
-
-
Quarles, L.D.1
-
4
-
-
0033800097
-
Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia
-
Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat. 2000;16(4):281-296
-
(2000)
Hum Mutat.
, vol.16
, Issue.4
, pp. 281-296
-
-
Hendy, G.N.1
D'Souza-Li, L.2
Yang, B.3
Canaff, L.4
Cole, D.E.5
-
5
-
-
65949083787
-
Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport
-
Vezzoli G, Soldati L, Gambaro G. Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr Pharm Biotechnol. 2009;10(3):302-310
-
(2009)
Curr Pharm Biotechnol.
, vol.10
, Issue.3
, pp. 302-310
-
-
Vezzoli, G.1
Soldati, L.2
Gambaro, G.3
-
6
-
-
38549095687
-
Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004)
-
Working Group on Calcium Metabolism
-
Mallet E; Working Group on Calcium Metabolism. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004). Horm Res. 2008;69(3): 180-188
-
(2008)
Horm Res
, vol.69
, Issue.3
, pp. 180-188
-
-
Mallet, E.1
-
7
-
-
5444235525
-
Neonatal severe hyperparathyroidism: Genotype/phenotype correlation and the use of pamidronate as rescue therapy
-
DOI 10.1007/s00431-004-1491-0
-
Waller S, Kurzawinski T, Spitz L, et al. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr. 2004;163(10):589-594 (Pubitemid 39362535)
-
(2004)
European Journal of Pediatrics
, vol.163
, Issue.10
, pp. 589-594
-
-
Waller, S.1
Kurzawinski, T.2
Spitz, L.3
Thakker, R.4
Cranston, T.5
Pearce, S.6
Cheetham, T.7
Van't, H.W.G.8
-
8
-
-
36048952655
-
Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant
-
Available at
-
Fox L, Sadowsky J, Pringle KP, et al. Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant. Pediatrics. 2007;120(5). Available at: www.pediatrics.org/cgi/content/full/120/5/e1350
-
(2007)
Pediatrics
, vol.120
, Issue.5
-
-
Fox, L.1
Sadowsky, J.2
Pringle, K.P.3
-
9
-
-
33745203732
-
Pediatric reference intervals for bone markers
-
Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem. 2006;39 (6):561-568
-
(2006)
Clin Biochem.
, vol.39
, Issue.6
, pp. 561-568
-
-
Yang, L.1
Grey, V.2
-
10
-
-
83155176197
-
Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta
-
Kitaoka T, Namba N, Miura K, et al. Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta. J Bone Miner Metab. 2011;29(5):598-605
-
(2011)
J Bone Miner Metab.
, vol.29
, Issue.5
, pp. 598-605
-
-
Kitaoka, T.1
Namba, N.2
Miura, K.3
-
11
-
-
0041842634
-
Bisphosphonate-induced osteopetrosis
-
DOI 10.1056/NEJMoa023110
-
Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003; 349(5):457-463 (Pubitemid 36910024)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.5
, pp. 457-463
-
-
Whyte, M.P.1
Wenkert, D.2
Clements, K.L.3
McAlister, W.H.4
Mumm, S.5
-
12
-
-
33845719009
-
Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children
-
DOI 10.1007/s00467-006-0306-0
-
Waterhouse KM, Auron A, Srivastava T, Haney C, Alon US. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. Pediatr Nephrol. 2007;22(2):282-287 (Pubitemid 44964330)
-
(2007)
Pediatric Nephrology
, vol.22
, Issue.2
, pp. 282-287
-
-
Waterhouse, K.M.1
Auron, A.2
Srivastava, T.3
Haney, C.4
Alon, U.S.5
-
13
-
-
55749104922
-
The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development
-
Chang W, Tu C, Chen TH, Bikle D, Shoback D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal. 2008;1(35):ra1
-
(2008)
Sci Signal.
, vol.1
, Issue.35
-
-
Chang, W.1
Tu, C.2
Chen, T.H.3
Bikle, D.4
Shoback, D.5
-
14
-
-
77954744645
-
The calcium-sensing receptor and 25-hydroxyvitamin D-1alpha-hydroxylase interact to modulate skeletal growth and bone turnover
-
Richard C, Huo R, Samadfam R, et al. The calcium-sensing receptor and 25-hydroxyvitamin D-1alpha-hydroxylase interact to modulate skeletal growth and bone turnover. J Bone Miner Res. 2010;25(7):1627-1636
-
(2010)
J Bone Miner Res.
, vol.25
, Issue.7
, pp. 1627-1636
-
-
Richard, C.1
Huo, R.2
Samadfam, R.3
-
15
-
-
57349098264
-
Novel inactivating mutations of the calcium-sensing receptor: The calcimimetic NPS R-568 improves signal transduction of mutant receptors
-
Rus R, Haag C, Bumke-Vogt C, et al. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors. J Clin Endocrinol Metab. 2008;93 (12):4797-4803
-
(2008)
J Clin Endocrinol Metab.
, vol.93
, Issue.12
, pp. 4797-4803
-
-
Rus, R.1
Haag, C.2
Bumke-Vogt, C.3
-
16
-
-
77954978874
-
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia
-
Alon US, VandeVoorde RG. Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr Nephrol. 2010;25(9):1747-1750
-
(2010)
Pediatr Nephrol.
, vol.25
, Issue.9
, pp. 1747-1750
-
-
Alon, U.S.1
VandeVoorde, R.G.2
|